JP2020055886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020055886A5 JP2020055886A5 JP2020005751A JP2020005751A JP2020055886A5 JP 2020055886 A5 JP2020055886 A5 JP 2020055886A5 JP 2020005751 A JP2020005751 A JP 2020005751A JP 2020005751 A JP2020005751 A JP 2020005751A JP 2020055886 A5 JP2020055886 A5 JP 2020055886A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- cancer
- rna
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023156026A JP2023165816A (ja) | 2017-11-09 | 2023-09-21 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017216336 | 2017-11-09 | ||
| JP2017216336 | 2017-11-09 | ||
| JP2019550876A JP6651061B2 (ja) | 2017-11-09 | 2018-11-06 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019550876A Division JP6651061B2 (ja) | 2017-11-09 | 2018-11-06 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023156026A Division JP2023165816A (ja) | 2017-11-09 | 2023-09-21 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020055886A JP2020055886A (ja) | 2020-04-09 |
| JP2020055886A5 true JP2020055886A5 (zh) | 2021-11-18 |
| JP7360705B2 JP7360705B2 (ja) | 2023-10-13 |
Family
ID=66437770
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019550876A Active JP6651061B2 (ja) | 2017-11-09 | 2018-11-06 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
| JP2020005751A Active JP7360705B2 (ja) | 2017-11-09 | 2020-01-17 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
| JP2023156026A Pending JP2023165816A (ja) | 2017-11-09 | 2023-09-21 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019550876A Active JP6651061B2 (ja) | 2017-11-09 | 2018-11-06 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023156026A Pending JP2023165816A (ja) | 2017-11-09 | 2023-09-21 | ｍｉＲＮＡを含むがん治療用医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11311568B2 (zh) |
| EP (4) | EP4265725A3 (zh) |
| JP (3) | JP6651061B2 (zh) |
| KR (1) | KR20200085801A (zh) |
| CN (4) | CN118615311A (zh) |
| AU (1) | AU2018364916B2 (zh) |
| CA (1) | CA3083756A1 (zh) |
| ES (1) | ES2956776T3 (zh) |
| WO (1) | WO2019093308A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021506815A (ja) | 2017-12-15 | 2021-02-22 | 株式会社スリー・ディー・マトリックス | 界面活性ペプチドナノ構造および薬物送達における使用 |
| CN112516317B (zh) * | 2020-12-10 | 2021-12-17 | 暨南大学附属第一医院（广州华侨医院） | 一种预防和治疗癌症的药物组合物及其应用 |
| KR20220169178A (ko) | 2021-06-18 | 2022-12-27 | 한국과학기술원 | 타겟 유전자 발현을 조절할 수 있는 헤어핀 구조의 핵산 분자 및 이의 용도 |
| KR20220169429A (ko) | 2021-06-18 | 2022-12-27 | 한국과학기술원 | 타겟 유전자 발현을 조절할 수 있는 핵산 분자 및 이의 용도 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5145557B2 (ja) * | 2007-03-01 | 2013-02-20 | 財団法人ヒューマンサイエンス振興財団 | マイクロｒｎａを有効成分として含有する腫瘍増殖抑制剤、および癌治療用医薬組成物 |
| CA2686165A1 (en) | 2007-05-03 | 2008-11-13 | Rosetta Inpharmatics Llc | Compositions comprising mir34 therapeutic agents for treating cancer |
| US9683232B2 (en) * | 2007-12-10 | 2017-06-20 | Kyoto University | Efficient method for nuclear reprogramming |
| JP5116026B2 (ja) | 2008-01-23 | 2013-01-09 | 富士フイルム株式会社 | 癌の検出方法および癌抑制剤 |
| JP5606318B2 (ja) | 2008-08-27 | 2014-10-15 | 株式会社スリー・ディー・マトリックス | トランスフェクション剤 |
| WO2010078037A2 (en) * | 2008-12-17 | 2010-07-08 | Synthes Usa, Llc | Full-metal dampening intervertebral implant |
| JP2010222338A (ja) * | 2009-02-27 | 2010-10-07 | Three D Matrix:Kk | 核酸移送担体 |
| EP3118334A1 (en) * | 2009-11-04 | 2017-01-18 | DiamiR, LLC | Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
| US20120315640A1 (en) | 2009-12-21 | 2012-12-13 | Hidetoshi Tahara | Senescence marker, method for evaluating senescence inhibitor, and cancer inhibitor |
| EP2518144B1 (en) | 2009-12-21 | 2015-08-05 | Hiroshima University | Aging marker, method for evaluating aging inhibitor, and cancer inhibitor |
| JP6155194B2 (ja) * | 2010-11-17 | 2017-06-28 | インターペース ダイアグノスティックス リミテッド ライアビリティ カンパニー | 良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのｍｉＲＮＡ |
| SG192707A1 (en) * | 2011-02-11 | 2013-09-30 | Univ Singapore | Treating cancer by inhibiting expression of olfm4, sp5, tobi, arjdia, fbni or hat1 |
| SG11201407696WA (en) * | 2012-05-31 | 2014-12-30 | Massachusetts Inst Technology | Sustained delivery of molecules using peptide surfactants and uses thereof |
| ES2927175T3 (es) * | 2013-02-12 | 2022-11-03 | Reneuron Ltd | Método de producción de micropartículas |
| WO2015020122A1 (ja) * | 2013-08-08 | 2015-02-12 | 国立大学法人 大阪大学 | 尿路上皮癌の診断または治療剤 |
| CN113633656A (zh) * | 2015-02-25 | 2021-11-12 | 柏业公司 | 包含微小核糖核酸作为活性成分的用于治疗癌症的药物组合物 |
-
2018
- 2018-11-06 US US16/760,817 patent/US11311568B2/en active Active
- 2018-11-06 EP EP23186073.5A patent/EP4265725A3/en active Pending
- 2018-11-06 EP EP23186136.0A patent/EP4276183A3/en active Pending
- 2018-11-06 JP JP2019550876A patent/JP6651061B2/ja active Active
- 2018-11-06 KR KR1020207015715A patent/KR20200085801A/ko not_active Application Discontinuation
- 2018-11-06 ES ES18876388T patent/ES2956776T3/es active Active
- 2018-11-06 CN CN202410346650.5A patent/CN118615311A/zh active Pending
- 2018-11-06 CN CN202410346729.8A patent/CN118615312A/zh active Pending
- 2018-11-06 WO PCT/JP2018/041139 patent/WO2019093308A1/ja unknown
- 2018-11-06 CA CA3083756A patent/CA3083756A1/en active Pending
- 2018-11-06 AU AU2018364916A patent/AU2018364916B2/en active Active
- 2018-11-06 EP EP23186139.4A patent/EP4276184A3/en active Pending
- 2018-11-06 EP EP18876388.2A patent/EP3708173B1/en active Active
- 2018-11-06 CN CN201880071699.7A patent/CN111405901A/zh active Pending
- 2018-11-06 CN CN202410346791.7A patent/CN118615313A/zh active Pending
-
2020
- 2020-01-17 JP JP2020005751A patent/JP7360705B2/ja active Active
-
2022
- 2022-03-15 US US17/694,982 patent/US12090167B2/en active Active
- 2022-03-15 US US17/695,079 patent/US20220202848A1/en active Pending
-
2023
- 2023-09-21 JP JP2023156026A patent/JP2023165816A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020055886A5 (zh) | ||
| JP7049262B2 (ja) | 結合組織成長因子を標的とするｒｎａ複合体を用いた特発性肺胞線維症の治療 | |
| JP7395483B2 (ja) | ｍＲＮＡの細胞内送達のためのペプチドおよびナノ粒子 | |
| JP6954843B2 (ja) | ペプチドオリゴヌクレオチドコンジュゲート | |
| CN107075515B (zh) | C/EBPα组合物和使用方法 | |
| ES2586593T3 (es) | Liposomas de retinoide para potenciar la modulación de la expresión de hsp47 | |
| US20150232847A1 (en) | Targeting oligonucleotides and related methods for modulating fxn rna | |
| US11904057B2 (en) | Nanoparticle-hydrogel composite for nucleic acid molecule delivery | |
| CN102459302A (zh) | 核酸递送组合物及其使用方法 | |
| JP7360705B2 (ja) | ｍｉＲＮＡを含むがん治療用医薬組成物 | |
| KR20180104692A (ko) | Angpt2 및 pdgfb를 표적화하는 rna 복합체를 사용하는 혈관신생 관련 질환의 치료 | |
| WO2019110067A1 (en) | Hybrid nanoparticle | |
| CN112143731B (zh) | 靶向破坏SARS-CoV-2病毒基因组的gRNA及其应用 | |
| US20180228830A1 (en) | Nucleic acid complex having at least one bulge structure | |
| WO2023013329A1 (ja) | ヘアピン核酸組成物 | |
| US11359200B2 (en) | Cancer treatment by MALAT1 inhibition | |
| US11566247B2 (en) | Modulation of alternative MDM2 splicing | |
| US20210130831A1 (en) | Lung-specific drug delivery system consisting of oligonucleotide polymers and biocompatible cationic peptides for the prevention or treatment of pulmonary fibrosis and use thereof | |
| US7528117B2 (en) | High efficacy antisense RIαPKA poly-DNP oligoribonucleotides | |
| JP7525578B2 (ja) | Ｃ／ＥＢＰα小分子活性化ＲＮＡ組成物 | |
| KR101780272B1 (ko) | siRNA의 동시 사일런싱이 가능한 RNA 전사체-DNA 접합체 하이브리드 및 이의 용도 | |
| EP4005602A1 (en) | Nucleic acid drug targeting murf1 | |
| CN116370491A (zh) | 反义寡核苷酸剂在治疗冠状病毒相关疾病中的应用 |